SEC 13F Intelligence

North Growth Management Ltd. / ABT

North Growth Management Ltd.’s Abbott Laboratories Position

Does North Growth Management Ltd. own Abbott Laboratories (ABT)? Not currently — the last reported position was 66.0K shares worth $9M in Q4 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$9M
Q4 2021
Shares
66.0K
% of Portfolio
+1.54%
Quarters Held
12
position exited

Position History ABT

Reported value by quarter
Q1 ’19: $10MQ1 ’19Q2 ’19: $10MQ3 ’19: $10MQ3 ’19Q4 ’19: $11MQ1 ’20: $8MQ1 ’20Q2 ’20: $7MQ3 ’20: $8MQ3 ’20Q4 ’20: $7MQ1 ’21: $8MQ1 ’21Q2 ’21: $8MQ3 ’21: $8MQ3 ’21Q4 ’21: $9Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 202166.0K$9M+1.54%
Q3 202166.0K$8M+1.37%
Q2 202166.0K$8M+1.24%
Q1 202165.0K$8M+1.39%
Q4 202065.0K$7M+1.47%
Q3 202070.0K$8M+1.68%
Q2 202077.0K$7M+1.70%
Q1 2020100.0K$8M+2.23%
Q4 2019121.0K$11M+2.36%
Q3 2019121.0K$10M+2.45%
Q2 2019121.0K$10M+2.52%
Q1 2019121.0K$10M+2.59%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See North Growth Management Ltd.’s full portfolio or all institutional holders of ABT.